<?xml version="1.0" encoding="UTF-8"?>
<p>Fungal diseases contribute to significant morbidity and mortality in humans. It is estimated that nearly a billion people are infected with mucosal or superficial fungal diseases and 150 million people are affected with invasive fungal diseases [
 <xref rid="B1-antibiotics-10-00051" ref-type="bibr">1</xref>]. The major invasive fungal infections include candidiasis, aspergillosis, cryptococcal meningitis, pneumocystis pneumonia, and histoplasmosis, which are responsible for over 1.6 million deaths globally [
 <xref rid="B1-antibiotics-10-00051" ref-type="bibr">1</xref>]. People with compromised immune systems (e.g., HIV/AIDS, neutropenia) or with underlying health conditions (e.g., cancer, organ transplant, diabetes) are some of the high-risk groups affected most by invasive fungal infections.
</p>
